ATE479436T1 - Strahlentherapieverstärker - Google Patents

Strahlentherapieverstärker

Info

Publication number
ATE479436T1
ATE479436T1 AT06730907T AT06730907T ATE479436T1 AT E479436 T1 ATE479436 T1 AT E479436T1 AT 06730907 T AT06730907 T AT 06730907T AT 06730907 T AT06730907 T AT 06730907T AT E479436 T1 ATE479436 T1 AT E479436T1
Authority
AT
Austria
Prior art keywords
amplifier
radiation therapy
radiotherapy
reduce
radiation
Prior art date
Application number
AT06730907T
Other languages
German (de)
English (en)
Inventor
Masakazu Fukushima
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE479436T1 publication Critical patent/ATE479436T1/de

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT06730907T 2005-04-01 2006-03-31 Strahlentherapieverstärker ATE479436T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005105819 2005-04-01
JP2006006959 2006-03-31

Publications (1)

Publication Number Publication Date
ATE479436T1 true ATE479436T1 (de) 2010-09-15

Family

ID=40336172

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06730907T ATE479436T1 (de) 2005-04-01 2006-03-31 Strahlentherapieverstärker

Country Status (2)

Country Link
AT (1) ATE479436T1 (es)
MX (1) MX2007012171A (es)

Also Published As

Publication number Publication date
MX2007012171A (es) 2007-12-07

Similar Documents

Publication Publication Date Title
DK1853250T3 (da) Kombinationer og måder til indgivelse af terapeutiske midler og kombinationsterapi
CY1123666T1 (el) Φαρμακευτικες ενωσεις
TW200621240A (en) Cancer treatments
ATE538103T1 (de) Chinazolinonverbindungen als antikrebsmittel
DE602004021838D1 (de) Substituierte benzazole und ihre verwendung als raf-kinase-hemmer
NO20063439L (no) Topical co-enzyme Q10 formulations and methods of use
TW200509931A (en) Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells, or angiogenesis
ATE428411T1 (de) Hdl-verstärkende kombinationstherapie-komplexe
GB2433070A (en) Porphyrin derivatives and their use in photon activation therapy
HK1078472A1 (en) Novel metalloporhyrins and their uses as radio sensitizers for radiation therapy
AR053338A1 (es) Terapia antiproliferativa combinada usando ciertos agentes quimioterapeuticos basados en platino y taxanos
CY1108395T1 (el) Ουσια επαυξησης της δρασης εναντι ογκων και παραγοντας εναντι ογκων
CY1111565T1 (el) Θεραπεια συνδυασμου του zd6474 με 5-fu και/ή cpt-11
ATE447960T1 (de) Antivirale verwendung von borinsäurekomplexen
ATE319718T1 (de) Oxazolo- und furopyrimidine und deren verwendung als medikamente gegen tumore
EP1864683A4 (en) RADIOSENSITIZING AGENT
DK1689404T3 (da) Kombination af et-743 med 5-fluoracil-prodrugs til behandling af cancer
SE0301654D0 (sv) Novel compounds
ATE479436T1 (de) Strahlentherapieverstärker
HK1079116A1 (en) Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy
DK1651774T3 (da) Anvendelse af polymorfier i humant OATP-C forbundet med en virkning på statinfarmakinetik i mennesker under statinterapi
MX2020006808A (es) Ubicar al complejo de signalosoma cbm induce a las celulas t reguladoras inflamar al microambiente tumoral.
TR200102557T2 (tr) Tiazonlindolinon bileşikleri.
UA88294C2 (ru) ПРИМЕНЕНИЕ АНТИ-α5β1 АНТИТЕЛ ДЛЯ УГНЕТЕНИЯ ПРОЛИФЕРАЦИИ РАКОВЫХ КЛЕТОК
DE602008004456D1 (de) Iger dosisrate

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties